🟢 NanoViricides is trading 6.86% up today with no clear catalyst identified

NanoViricides is trading 6.86% up at $1.06, reversing from its September 11 close of $1.02; no clear company-specific catalyst was identified.

• No new company-specific announcement dated September 14, 2026 was identified.
• September 8 saw registration of the Phase II NV-387 Ebola trial in the Democratic Republic of Congo, but sources do not explicitly connect it to the move.
• The broader market is weaker, so market sentiment does not explain the gain.